Under the agreement, teams from Geisinger and Merck will work together to develop a number of tools that will initially be tested at Geisinger. The first is an interactive web application designed to help primary care clinicians assess and engage patients at risk for cardiometabolic syndrome.
“We believe that healthcare is most effective when patients are active partners in their care,” said Glenn Steele Jr., MD, PhD, president and CEO of Geisinger. “Our collaboration with Merck will allow both organizations to leverage our individual expertise and joint resources to improve patient engagement, including finding new interventions to increase the likelihood that patients will adhere to their treatment plans.”
More Articles on Geisinger Health System:
Pennsylvania AG Imposes Provisions on Geisinger Health’s Acquisition of Bloomsburg Hospital
Geisinger Medical Center in Pennsylvania to Build $52.8M Patient Lab
Geisinger Health’s Earnings Per Bed Up 116% in 2011
